Puma Biotechnology Reports Third Quarter 2021 Financial Results | Business Wire
Is Puma off the cancer M&A list? With Nerlyx marketing deal, some investors think so | Fierce Pharma
Puma Bio FDA Advisory Panel Live Blog - TheStreet
Puma Biotechnology Inc (PBYI) Stock: Do Analysts Think You Should Sell?
Puma Biotechnology
Puma Bio: A Contrarian Investment That Requires Patience (NASDAQ:PBYI) | Seeking Alpha
Why Puma Biotechnology, Inc. Stock Crashed 37% in March | The Motley Fool
Puma Biotechnology's (PBYI) Lowest Price: $1.6400 (on 05-11-2022)
Puma Biotechnology Reports Third Quarter 2022 Financial Results | Business Wire
Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
Articles with Puma Biotechnology
Puma Biotechnology: Still Bullish At These Prices (NASDAQ:PBYI) | Seeking Alpha
Is Puma Biotechnology, Inc. (NASDAQ:PBYI) Popular Amongst Insiders?
Compra Acciones de Puma Biotechnology Inc y Comprueba ($PBYI) su Precio de Mercado en eToro.
Federal Jury Awards Puma Biotechnology Investors Damages in Securities Class-Action Verdict - Los Angeles Business Journal
With 53% institutional ownership, Puma Biotechnology, Inc. (NASDAQ:PBYI) is a favorite amongst the big guns | Nasdaq
Puma Biotechnology (PBYI) - 5 Price Charts 2012-2022 (History)
Why Puma Biotechnology, Inc. Stock Crashed 37% in March | Fox Business
Puma Biotech (PBYI) Stock up as Q2 Earnings & Sales Beat
Puma Biotechnology
PBYI Institutional Ownership and Shareholders - Puma Biotechnology Inc (NASDAQ) Stock
